Enanta Pharmaceuticals, Inc. ENTA
ENTA
Enanta Pharmaceuticals, Inc. PYXS
Pyxis Oncology, Inc. PRLD
Prelude Therapeutics Incorporated TNYA
Tenaya Therapeutics, Inc. FHTX
Foghorn Therapeutics Inc. NAUT
Nautilus Biotechnology, Inc. CRBU
Caribou Biosciences, Inc. IMRX
Immuneering Corporation VYGR
Voyager Therapeutics, Inc. AVIR
Atea Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc. PYXS
Pyxis Oncology, Inc. PRLD
Prelude Therapeutics Incorporated TNYA
Tenaya Therapeutics, Inc. FHTX
Foghorn Therapeutics Inc. NAUT
Nautilus Biotechnology, Inc. CRBU
Caribou Biosciences, Inc. IMRX
Immuneering Corporation VYGR
Voyager Therapeutics, Inc. AVIR
Atea Pharmaceuticals, Inc.
Performance
| Periode | ENTA | PYXS | PRLD | TNYA | FHTX | NAUT | CRBU | IMRX | VYGR | AVIR |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 96.67 % | 258.33 % | 78.63 % | 42.05 % | 3.47 % | 163.91 % | 61.71 % | 220.79 % | 32.87 % | -0.16 % |
| YTD | 163.86 % | 154.44 % | 37.20 % | -40.83 % | -2.61 % | 9.47 % | 6.85 % | 175.79 % | -26.56 % | -7.75 % |
| 1Y | 133.76 % | 155.95 % | 91.47 % | -70.83 % | -18.87 % | -7.50 % | -6.02 % | 252.31 % | -32.34 % | 1.77 % |
| 3Y | -66.85 % | 267.52 % | -67.02 % | -65.85 % | -32.88 % | 14.20 % | -78.00 % | 24.64 % | -24.92 % | -28.46 % |
| 5Y | -65.29 % | -67.42 % | -97.64 % | -94.53 % | -77.65 % | -82.71 % | -89.00 % | -65.35 % | -47.86 % | -89.84 % |
| 10Y | -50.62 % | -67.42 % | -93.45 % | -94.53 % | -75.33 % | -82.28 % | -89.00 % | -65.35 % | -79.12 % | -89.60 % |
| From the beginning | -14.14 % | -67.42 % | -93.45 % | -94.53 % | -75.33 % | -82.28 % | -89.00 % | -65.35 % | -75.30 % | -89.60 % |